The Challenge

The National Institute of Cancer Research & Hospital (NICRH) in Mohakhali, Dhaka, serves as Bangladesh's primary national cancer centre, treating thousands of patients across oncology, haematology, surgical oncology, radiotherapy, and palliative care. Its laboratory is one of the most diagnostically complex in the country — processing histopathology, flow cytometry, tumour markers, molecular diagnostics, and a continuous stream of chemotherapy fitness panels simultaneously. By 2022, several critical problems had reached a breaking point:

• Chemotherapy fitness panels — the mandatory pre-chemo blood tests (full blood count, renal function, liver function) that must clear safety thresholds before a cycle can proceed — were managed on paper checklists. Incomplete panels occasionally resulted in chemotherapy being administered without all results available, creating serious patient safety incidents.
• NICRH's histopathology and cytology sections used entirely separate paper-based reporting systems from the clinical biochemistry and haematology laboratories. Oncologists frequently needed to cross-reference results from multiple departments for treatment planning, requiring them to physically visit multiple report counters or wait for nursing staff to collate reports manually — a process that regularly took 24–48 hours.
• Tumour marker trending — the longitudinal tracking of markers like PSA, CA-125, CA 19-9, AFP, and CEA across a patient's treatment history — was done by clinical staff manually reviewing paper records, making it extremely difficult to visualize treatment response trajectories or identify early relapse signals.
• NICRH's cancer registry, maintained for national epidemiological reporting, was populated by manual data entry from lab reports — a process that introduced transcription errors and created significant administrative overhead for the registry team.

The Solution

Logic & Pixel Technologies delivered an oncology-specialized LIS for NICRH, incorporating features developed specifically in consultation with NICRH's oncologists, pathologists, and haematologists — representing a genuinely novel configuration in Bangladeshi healthcare informatics:

• Chemotherapy Fitness Panel Gate: A mandatory digital pre-chemo checklist embedded in the LIS workflow. Chemotherapy approval documentation cannot be generated unless all required fitness panel results have been validated and cleared against NICRH's protocol thresholds — creating a hard system-level safety gate that replaces the old paper checklist.
• Unified Oncology Report View: A single consolidated patient view that presents results from all laboratory departments — biochemistry, haematology, histopathology, cytology, microbiology, and molecular — in a single chronological interface. Oncologists can review a patient's complete diagnostic picture without visiting multiple counters or waiting for manual report collation.
• Tumour Marker Trend Visualization: Interactive graphical trend charts for all monitored tumour markers across a patient's complete treatment history, automatically generated within the LIS report view. Oncologists can visualize response patterns, identify plateau, relapse, or progression signals, and export charts directly for tumour board presentations.
• Cancer Registry Auto-Population: Validated diagnostic results that meet registry inclusion criteria are automatically flagged and pre-populated into NICRH's national cancer registry database, with clinical staff performing confirmation review only — eliminating manual transcription and dramatically reducing registry data entry workload.
• Histopathology & Cytology Digital Workflow: Biopsy and cytology specimen tracking from receipt through processing, staining, microscopy, reporting, and archive — fully digitized with barcode-tracked specimen blocks and a structured digital reporting template aligned with international CAP cancer reporting protocols.

The Implementation

NICRH's implementation presented the most complex configuration challenge in our portfolio. The breadth of laboratory disciplines — ranging from routine biochemistry to specialized molecular pathology — required our configuration team to conduct individual workflow design sessions with each department head over a six-week discovery phase. This produced a detailed functional specification that was reviewed and signed off by NICRH's director of laboratory services before any technical deployment commenced.

Deployment occurred in three phases: clinical biochemistry and haematology first (weeks 1–3), followed by histopathology and cytology (weeks 4–6), and finally the cancer registry integration and tumour marker visualization module (weeks 7–9). Each phase included a one-week parallel-run validation period before the next phase commenced. Intensive training was provided in Bengali across 12 scheduled sessions covering all staff categories, with supplementary quick-reference guides printed and posted at every workstation.

The Results

At the six-month post-implementation review, NICRH's clinical governance and quality committee documented the following outcomes against its pre-implementation baseline:

• 72% reduction in chemotherapy pre-treatment laboratory protocol errors — defined as any instance where chemotherapy administration documentation was progressed with incomplete or unvalidated fitness panel results.
• Oncologist time spent locating and collating multi-department results for treatment planning reduced by an estimated 60%, based on a structured time-motion study conducted by NICRH's quality team.
• Cancer registry data entry workload reduced by 80%, with registry data completeness improving from 74% to 97% due to automated population from validated LIS records.
• Histopathology report turnaround for surgical biopsy specimens improved from an average of 9 working days to 5.5 working days — a 39% improvement attributed to digitized workflow tracking eliminating specimen location uncertainty.
• Tumour board meeting preparation time reduced significantly, with oncologists reporting that the ability to present graphical marker trend charts directly from the LIS — rather than constructing them manually from paper records — saved approximately 2–3 hours per patient presentation.

Client Quote

"Cancer care is a longitudinal journey — we follow patients for years. We need a system that remembers every result, every marker, every biopsy, in a way that makes clinical sense. Logic & Pixel built that system for us. The chemo safety gate alone has transformed our clinical risk posture. But the tumour marker trending? Our oncologists use it at every tumour board meeting. This is genuinely the most impactful IT investment NICRH has made in a decade." — Prof. Dr. Md. Hafizur Rahman, Director, National Institute of Cancer Research & Hospital (NICRH), Mohakhali, Dhaka